JP Morgan Chase
ASMB icon

JP Morgan Chase’s Assembly Biosciences ASMB Stock Holding History

JP Morgan Chase’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
46,385
-7,577
-14% -$206K ﹤0.01% 4522
2026
Q1 		$1.44M Buy
53,962
+5,803
+12% +$166K ﹤0.01% 4338
2025
Q4 		$1.64M Buy
48,159
+48,152
+687,886% +$1.55M ﹤0.01% 4245
2025
Q3 		$179 Hold
7
– – ﹤0.01% 7123
2025
Q2 		$127 Hold
7
– – ﹤0.01% 6813
2025
Q1 		$67 Sell
7
-11,420
-100% -$149K ﹤0.01% 6930
2024
Q4 		$180K Buy
11,427
+7,918
+226% +$127K ﹤0.01% 5517
2024
Q3 		$53.1K Buy
3,509
+3,442
+5,137% +$52.4K ﹤0.01% 5967
2024
Q2 		$919 Buy
67
+60
+857% +$856 ﹤0.01% 6631
2024
Q1 		$93 Sell
7
-1
-13% -$12 ﹤0.01% 6915
2023
Q4 		$77 Sell
8
-5
-38% -$48 ﹤0.01% 7149
2023
Q3 		$137 Buy
13
+5
+63% +$60 ﹤0.01% 6880
2023
Q2 		$109 Hold
8
– – ﹤0.01% 6686
2023
Q1 		$0 Hold
8
– – ﹤0.01% 6674
2022
Q4 		$0 Hold
8
– – ﹤0.01% 6525
2022
Q3 		$0 Sell
8
-519
-98% -$12.6K ﹤0.01% 6443
2022
Q2 		$13K Sell
527
-705
-57% -$16.2K ﹤0.01% 5981
2022
Q1 		$30K Buy
1,232
+1,224
+15,300% +$26.3K ﹤0.01% 5960
2021
Q4 		$0 Sell
8
-239
-97% -$7.84K ﹤0.01% 6621
2021
Q3 		$10K Sell
247
-4,380
-95% -$184K ﹤0.01% 6162
2021
Q2 		$216K Sell
4,627
-18,717
-80% -$927K ﹤0.01% 5203
2021
Q1 		$1.29M Buy
23,344
+11,781
+102% +$781K ﹤0.01% 4035
2020
Q4 		$840K Sell
11,563
-515
-4% -$60.4K ﹤0.01% 4063
2020
Q3 		$2.36M Sell
12,078
-884
-7% -$223K ﹤0.01% 3129
2020
Q2 		$3.63M Sell
12,962
-6,382
-33% -$1.49M ﹤0.01% 2700
2020
Q1 		$3.44M Buy
19,344
+2,934
+18% +$629K ﹤0.01% 2556
2019
Q4 		$4.03M Sell
16,410
-6,666
-29% -$1.23M ﹤0.01% 2857
2019
Q3 		$2.72M Buy
23,076
+4,654
+25% +$704K ﹤0.01% 3199
2019
Q2 		$3.06M Buy
18,422
+1,470
+9% +$279K ﹤0.01% 3061
2019
Q1 		$4M Buy
16,952
+9,883
+140% +$2.5M ﹤0.01% 2773
2018
Q4 		$1.92M Buy
7,069
+172
+2% +$49.8K ﹤0.01% 3306
2018
Q3 		$3.07M Buy
6,897
+251
+4% +$118K ﹤0.01% 3143
2018
Q2 		$3.13M Sell
6,646
-2,411
-27% -$1.27M ﹤0.01% 3057
2018
Q1 		$5.34M Sell
9,057
-1,976
-18% -$1.23M ﹤0.01% 2525
2017
Q4 		$5.99M Sell
11,033
-3,743
-25% -$1.69M ﹤0.01% 2536
2017
Q3 		$5.94M Buy
14,776
+951
+7% +$291K ﹤0.01% 2424
2017
Q2 		$3.43M Buy
+13,825
New +$3.89M ﹤0.01% 2727
2016
Q4 		– Sell
-192
Closed -$17K – 4992
2016
Q3 		$17K Buy
192
+95
+98% +$7.34K ﹤0.01% 4221
2016
Q2 		$7K Buy
+97
New +$6.37K ﹤0.01% 4392

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

JP Morgan Chase's ASMB Position: Q2 2026 in Review

JP Morgan Chase reduced its Assembly Biosciences (ASMB) stake by 14% in Q2 2026, selling an estimated $206K and leaving 46,385 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #4522.

JP Morgan Chase first reported a position in ASMB in Q2 2016 and has held it in 39 quarters since. The position peaked at $5.99M in Q4 2017. 92 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • JP Morgan Chase held 46,385 shares of Assembly Biosciences worth $1.25M as of Q2 2026.
  • JP Morgan Chase sold 7,577 Assembly Biosciences shares in Q2 2026, an estimated $206K.
  • Assembly Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4522 holding.
  • JP Morgan Chase first reported a position in Assembly Biosciences in Q2 2016 and has held it in 39 quarters since.
  • JP Morgan Chase's Assembly Biosciences position peaked at $5.99M in Q4 2017.
  • 92 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.